Cefpirome & Sulbactam Injection Manufacturer in India

Product Overview
Key Features
Therapeutic Uses
Dosage Form Advantages

Genliva Wellness LLP develops Cefpirome & Sulbactam Injection for life-threatening bacterial infections requiring aggressive injectable antibacterial therapy in intensive care and hospital environments. The formulation is widely utilized in septicemia, ventilator-associated pneumonia, complicated respiratory infections, urinary tract infections, and post-operative bacterial complications involving resistant pathogens.

Cefpirome belongs to the fourth-generation cephalosporin category and demonstrates extended antibacterial activity against difficult gram-positive and gram-negative bacterial organisms. Sulbactam enhances antibacterial effectiveness by neutralizing beta-lactamase enzymes produced by resistant bacteria, improving overall infection control in critical conditions.

As a leading Cefpirome & Sulbactam Injection Manufacturer in India, Genliva Wellness LLP specializes in sterile injectable antibiotic manufacturing for hospital procurement programs, institutional pharmaceutical supply, and international injectable export markets.

Cefpirome & Sulbactam Injection is formulated for resistant bacterial infection treatment in critical care settings.

Fourth-generation cephalosporin sterile injection
Dual antibacterial and beta-lactamase inhibitor action
Frequently utilized in ICU antibacterial protocols
Extended-spectrum injectable antibacterial profile
Manufactured under stringent sterile standards
Developed for hospital infection management programs

This injectable formulation is prescribed in severe and resistant bacterial infection therapies.

Treatment of septicemia and ventilator-associated pneumonia
Management of complicated respiratory infections
Administered in urinary tract bacterial conditions
Prescribed in post-surgical infection control
Utilized in hospital-acquired bacterial infections
Frequently selected in critical care antibacterial therapies

Cefpirome & Sulbactam Injection delivers advanced antibacterial coverage in severe infections.

Broad-spectrum action against resistant bacteria
Valuable in ICU and emergency antibacterial care
Beta-lactamase inhibition strengthens antibiotic activity
Rapid injectable administration in critical conditions
Frequently utilized in institutional healthcare programs
Effective for severe hospital bacterial infections